Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for children with bladder pain syndrome
IRCT20210628051728N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of montelukast in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Change in urinary frequency, Change in nocturia and 3 more. Started Aug 2021; status: completed.
02
Drugs
montelukast
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on IRCT20210628051728N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210628051728N1.